Real-time enrollment status for this bipolar depression clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 3:48 PM UTC
| NCT Number | NCT06656416 |
| Recruiting Status | Recruiting |
| Condition | Bipolar Depression |
| Phase | PHASE2 |
| Target Enrollment | 200 participants |
| Active Locations | 58 sites in the US |
| Sponsor | Alto Neuroscience |
| Last Updated on CT.gov | October 13, 2026 (3 days ago) |
As of October 16, 2026: Clinical trial NCT06656416 is currently recruiting participants. This phase2 study for bipolar depression is actively seeking new participants at 58 locations across the United States. The study is sponsored by Alto Neuroscience. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06656416 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 58 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06656416 was last updated 3 days ago (October 13, 2026). HelloStudys verifies this status automatically.